Results 181 to 190 of about 20,764 (191)

Incidence and risk factors for nevirapine-associated rash

European Journal of Clinical Pharmacology, 2003
Eric C. M. van Gorp, Jos Beijnen, Alwin D R Huitema   +2 more
exaly  

Nevirapine

Reactions Weekly, 2010
openaire   +2 more sources

Serum nevirapine and efavirenz concentrations and effect of concomitant rifampicin in HIV infected children on antiretroviral therapy

Indian Pediatrics, 2011
Ira Shah, Soumya Swaminathan, A K Hemanth Kumar   +2 more
exaly  

Case-Control Exploration of Relationships Between Early Rash or Liver Toxicity and Plasma Concentrations of Nevirapine and Primary Metabolites

HIV Clinical Trials, 2007
Thomas R Macgregor
exaly  

Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals

British Journal of Clinical Pharmacology, 2002
Eric C. M. van Gorp, Jos Beijnen, Alwin D R Huitema   +2 more
exaly  

Evidence for nevirapine bioactivation in man: Searching for the first step in the mechanism of nevirapine toxicity

Toxicology, 2012
Aline Marinho, Nádia M Grilo, Umbelina Caixas   +2 more
exaly  

Comparison of Nevirapine- and Efavirenz-Containing Antiretroviral Regimens in Antiretroviral-Naïve Patients: A Cohort Study

HIV Clinical Trials, 2002
Philip Keiser
exaly  

Nevirapine induces growth arrest and premature senescence in human cervical carcinoma cells

Gynecologic Oncology, 2008
Alexandros Rodolakis, George S Vlachos, Aris Antsaklis   +2 more
exaly  

HEPATOTOXICITY FOLLOWING NEVIRAPINE-CONTAINING REGIMENS IN HIV-1-INFECTED INDIVIDUALS

Pharmacological Research, 2002
Eric C. M. van Gorp, Jos Beijnen, Alwin D R Huitema   +2 more
exaly  

Efavirenz and Nevirapine in HIV-1 Infection

Clinical Pharmacokinetics, 2012
Karen Dahri
exaly